This study aim to evaluate the effect of virtual reality distraction on symptom management and anxiety in children aged 7-18 years with leukemia.
While the virtual reality initiative was applied to the children in the study group, no harm was given to the children in the control group. The virtual reality distraction method will not be applied to the control group. After the child and his family are informed about the study, their written informed consent will be obtained. When the patients were admitted to the clinic the day before chemotherapy treatment was started, the symptom screening scale and anxiety scale will be applied. Control Group: The researcher stated that no additional procedure will be applied to the children in the control group and that the symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days. VR group; A distraction intervention will be applied for 10-15 minutes once a day with VR glasses. The symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
40
virtual reality distraction
Gülçin Özalp Gerçeker
Izmir, Turkey (Türkiye)
RECRUITINGFigen Yardımcı
Izmir, Turkey (Türkiye)
RECRUITINGChange in symptom cluster
Symptom by Symptom Screening Tool(8-18) in SSPedi-Pediatric Patients with Cancer
Time frame: during the 1st, 2nd and 3rd days of chemotherapy treatment
Change in anxiety
anxiety by State-Trait Anxiety Inventory for Children
Time frame: (during the 1st, 2nd and 3rd days of chemotherapy treatment)
Gülçin Özalp Gerçeker, pHD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.